Christopher Trotta
10Patents
3h-index
30Co-inventors
56Inventor score
Filing activity: Mar 26, 2004 → Jun 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8426194B2 | Methods and agents for screening for compounds capable of modulating VEGF expression | Physics | 14 | Active |
| US8076353B2 | Inhibition of VEGF translation | Chemistry; Metallurgy | 13 | Active |
| US9351964B2 | Methods for treating cancer and non-neoplastic conditions | Emerging Cross-Sectional Technologies | 5 | Active |
| US9068234B2 | Methods and agents for screening for compounds capable of modulating gene expression | Physics | 1 | Active |
| US8278085B2 | RNA processing protein complexes and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11608501B2 | Methods for modifying RNA splicing | Chemistry; Metallurgy | 0 | Active |
| US9476870B2 | Methods and agents for screening for compounds capable of modulating gene expression | Physics | 0 | Active |
| US7829503B2 | Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents | Chemistry; Metallurgy | 0 | Expired |
| US11702646B2 | Methods for modulating RNA splicing | Chemistry; Metallurgy | 0 | Active |
| US7939468B2 | Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.